Genetic association and computational analysis of MTHFR gene polymorphisms rs1801131 and rs1801133 with breast cancer in the Bangladeshi population

被引:0
|
作者
Alam, Nazia Fairooz [1 ]
Ahmed, Rubaiat [2 ]
Mahmud, Zimam [1 ]
Tamanna, Sonia [1 ]
Shaon, Md Akeruzzaman [1 ]
Howlader, Md. Zakir Hossain [1 ]
机构
[1] Univ Dhaka, Dept Biochem & Mol Biol, Lab Nutr & Hlth Res, Dhaka 1000, Bangladesh
[2] Natl Inst Biotechnol, Mol Biotechnol Div, Dhaka 1349, Bangladesh
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
Methylenetetrahydrofolate reductase; Genetic polymorphisms; rs1801133; rs1801131; PCR-RFLP; Bangladeshi population; PROTEIN MUTATIONS; RISK; SUSCEPTIBILITY; VARIANTS; STABILITY; GENOTYPE; IMPACT; SERVER; C677T; WEB;
D O I
10.1038/s41598-024-75656-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Methylenetetrahydrofolate reductase (MTHFR) plays a crucial role in regulating one-carbon metabolism. Polymorphisms within the MTHFR gene have been found to increase the risk of breast cancer in different populations. In this study, we evaluated the association of polymorphisms of the MTHFR gene (rs1801133 and rs1801131) with the risk of breast cancer in the Bangladeshi population. This case-control study included 202 breast cancer patients and 104 healthy controls. After the organic extraction of DNA, genotyping was performed via the PCR-RFLP method. Sanger sequencing was performed to validate the RFLP data. Statistical analyses were performed to evaluate the associations of the polymorphisms. Different computational tools were used to predict the structural and functional consequences of the SNPs. Our study revealed that the MTHFR gene polymorphism rs1801131 is associated with an increased risk of developing breast cancer (p < 0.001, OR = 3.85, 95% CI = 2.06-7.25 for the AC genotype and p < 0.001, OR = 7.82, 95% CI = 2.69-22.05 for the CC genotype). An association was also observed in the dominant model (AC + CC) (p < 0.001, OR = 4.19, 95% CI = 2.28-7.78). For rs1801131, premenopausal status was significantly associated with breast cancer risk (p < 0.001). For rs1801133, no significant association was found with breast cancer risk (p > 0.05, OR = 1.57, 95% CI = 0.90-2.74 for the CT genotype; p > 0.05, OR = 1.35, 95% CI = 0.36-4.92 for the TT genotype). Computational analyses predicted rs1801131 to be tolerated and rs1801133 to be deleterious. Structural analyses demonstrated no significant changes in protein structure but revealed alterations in neighboring interactions according to both bond distances and angles. In conclusion, rs1801131 but not rs1801133 is significantly associated with breast cancer risk in the Bangladeshi population. Moreover, in silico analyses demonstrated changes in the interaction pattern of polymorphic residues with adjacent amino acids.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: A meta-analysis
    Zhang, Hua-Zhu
    Wu, Jiang-Hai
    Huang, Qian
    Yang, Qin
    Sima, Quan
    Chen, Ke-Yan
    Li, Zhi-Ran
    He, Gong-Hao
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (07) : 2359 - 2368
  • [2] Association analysis of MTHFR (rs1801133 and rs1801131) and MTRR (rs1801394) gene polymorphisms towards the development of hypertension in the Bai population from Yunnan, China
    Liu, Yongxin
    Xu, Chunping
    Wang, Yuqing
    Yang, Caiting
    Pu, Genyuan
    Zhang, Le
    Wang, Zhuang
    Tao, Pengyan
    Hu, Shenghe
    Lai, Mingming
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2023, 45 (01)
  • [3] Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients
    Yuan, Lamei
    Song, Zhi
    Deng, Xiong
    Xiong, Wei
    Yang, Zhijian
    Deng, Hao
    NEUROSCIENCE LETTERS, 2016, 616 : 26 - 31
  • [4] Association of the rs1801133 and rs1801131 polymorphisms in the MTHFR gene and the adverse drug reaction of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients
    Mutlak, Qassim Mahdi
    Kasim, Ali Abdulhussain
    PHARMACIA, 2024, 71 : 1 - 8
  • [5] Methylenetetrahydrofolate Reductase Gene rs1801133 and rs1801131 Polymorphisms and Essential Hypertension Risk: A Comprehensive Analysis
    Fan, Yingchao
    Wu, Liting
    Zhuang, Wenfang
    CARDIOVASCULAR THERAPEUTICS, 2022, 2022
  • [6] Genetic variants and breast carcinoma susceptibility: Unveiling the role of MTHFR (rs1801131, rs1801133) and TP53 (rs1042522)
    Nouh, Walaa E.
    Azab, Eman Fawzy
    Oraby, Enas A.
    Ahmed, Shaymaa M.
    El-Eshmawy, Mohamed Adel
    Badawy, Heba K.
    Shaaban, Esraa Ibrahim A.
    El-Beltagy, Nanis S.
    Abu Alrub, Heba
    Wahsh, Eman
    Elmashad, Hanan Awad M.
    Elsaid, Afaf M.
    Elhassan, Thoraya Mohamed
    Toraih, Eman
    Elshazli, Rami M.
    Alalawy, Adel I.
    Attia, Zeinab R.
    GENE, 2025, 942
  • [7] ACUTE PERITONITIS AND POSSIBLE CONNECTION WITH 5,10-METHYLENETETRAHYDROFOLATEREDUCTASE GENE POLYMORPHISMS rs1801133 AND rs1801131
    Karol, I. V.
    Ziablitsev, S. V.
    Bilyayeva, O. O.
    WORLD OF MEDICINE AND BIOLOGY, 2024, 88 (02): : 77 - 81
  • [8] Association of 677 C&gt;T (rs1801133) and 1298 A&gt;C (rs1801131) Polymorphisms in the MTHFR Gene and Breast Cancer Susceptibility: A Meta-Analysis Based on 57 Individual Studies
    Li, Kai
    Li, Wusheng
    Dong, Xi
    PLOS ONE, 2014, 9 (06):
  • [9] Association analysis of MTHFR (rs1801133 and rs1801131) gene polymorphism towards the development of type 2 diabetes mellitus in Dali area population from Yunnan Province, China
    Liu, Yongxin
    Pu, Genyuan
    Yang, Caiting
    Wang, Yuqing
    Jin, Kaitai
    Wang, Shengrong
    Liang, Xiao
    Hu, Shenghe
    Sun, Shuguang
    Lai, Mingming
    PEERJ, 2024, 12
  • [10] Association of Two Methylenetetrahydrofolate Reductase Polymorphisms (rs1801133, rs1801131) with the Risk of Type 2 Diabetes in South-East of Iran
    Poodineh, Maryam
    Saravani, Ramin
    Mirhosseini, Mahboubeh
    Sargazi, Saman
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 8 (02): : 178 - 183